Chan Breaks Down the Need for Dose Escalation With Somatostatin Analogs in GEP-NETs | OncLive Jennifer Chan, MD, MPH, discusses dose escalation and interval shortening with somatostatin analogs for GEP-NETs and how SORENTO may shape treatment.

Chan Breaks Down the Need for Dose Escalation With Somatostatin Analogs in GEP-NETs @danafarber.bsky.social @harvardmed.bsky.social @nanets.bsky.social #NANETS25 #medtwitter #oncology www.onclive.com/view/chan-br...

Read more about these exciting #oncology updates from #NANETS25 with Daneng Li from @cityofhope.bsky.social here: ▶️https://bit.ly/3JIMaSy

#cancerResearch

Longer OS Observed in Patients With Stage IV Rectal SCC Than Stage IV Colon SCC Researchers have identified a pattern of longer overall survival in patients with stage IV rectal SCC than among patients with stage IV colon SCC.

Researchers have identified a pattern of longer OS in patients with stage IV rectal small cell carcinoma than among patients with stage IV colon SCC. Presented at #NANETS25.

https://bit.ly/3LeExUi

#gicsm